Financials data is unavailable for this security.
View more
Year on year Chemclin Diagnostics Co Ltd 's revenues fell -4.28% from 465.27m to 445.34m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 152.63m to 147.37m, a -3.44% decrease.
| Gross margin | 74.89% |
|---|---|
| Net profit margin | 31.38% |
| Operating margin | 35.58% |
| Return on assets | 7.82% |
|---|---|
| Return on equity | 10.08% |
| Return on investment | 8.73% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Chemclin Diagnostics Co Ltd fell by 90.54m. However, the company earned 173.05m from its operations for a Cash Flow Margin of 38.86%. In addition the company generated 44.01m cash from financing while 307.68m was spent on investing.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 3.49 |
|---|---|
| Tangible book value per share | 2.98 |
More ▼
Balance sheet in CNYView more
| Current ratio | 5.76 |
|---|---|
| Quick ratio | 5.16 |
| Total debt/total equity | 0.1785 |
|---|---|
| Total debt/total capital | 0.1515 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -63.98% and -3.44%, respectively.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 35.41% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -9.84 |
More ▼
